vTv Therapeutics LLC, a clinical-stage pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. It has a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. The company’s core focus is in Alzheimer's disease and Type 2 diabetes. It is also engaged in the discovery of preclinical and clinical drug candidates against multiple molecular target classes, such as kinases, GPCRs, phosphatases, proteases, and protein-protein interactions. vTv Therapeutics LLC was formerly known as TransTech Pharma, LLC and changed its name to vTv Therapeutics LLC in May, 2015. The company was founded in 1998 and is based in High Point, North Carolina. vTv Therapeutics LLC operates as a subsidiary of vTv Therapeutics Inc.